Literature DB >> 3628751

Mammography screening: successes and problems in implementing widespread use in the United States.

R H Gold, L W Bassett, S A Fox.   

Abstract

Deterrents to the use of screening mammography include perceived risks of radiation, perceived "unnecessary" biopsies and overdiagnosis, and high cost. In addition, physicians and patients have attitudinal barriers that do not reflect objective realities. Professional and public education efforts are needed to enable women and their physicians to develop a more sophisticated understanding of the usefulness of screening mammography and the role played by the radiologist. As part of their efforts to increase the implementation of screening mammography, the American College of Radiology has developed a Mammography Accreditation Program for radiological facilities and has produced a free Mammography Resource Kit for radiologists, while the American Cancer Society has undertaken the support of local and national campaigns to establish screening programs at reduced cost. Both organizations continue to strive in partnership to increase the acceptance of screening throughout the United States.

Entities:  

Mesh:

Year:  1987        PMID: 3628751

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

1.  Urban black women's perceptions of breast cancer and mammography.

Authors:  J H Price; S M Desmond; S Slenker; D Smith; P W Stewart
Journal:  J Community Health       Date:  1992-08

2.  Breast cancer risk and participation in mammographic screening.

Authors:  S Taplin; C Anderman; L Grothaus
Journal:  Am J Public Health       Date:  1989-11       Impact factor: 9.308

3.  Health Belief Model variables as predictors of screening mammography utilization.

Authors:  R B Hyman; S Baker; R Ephraim; A Moadel; J Philip
Journal:  J Behav Med       Date:  1994-08

4.  Breast cancer beliefs of women participating in a television-promoted mammography screening project.

Authors:  S M Fuller; R J McDermott; R G Roetzheim; P J Marty
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.